Generation Bio
Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.
Domain
generationbio.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$76.0M
Founded
2015
Tech Stack (4 technologies)
Frequently Asked Questions
What technologies does Generation Bio use?+
Generation Bio uses 4 technologies including Basic, Font Awesome, Google Font API.
What industry is Generation Bio in?+
Generation Bio operates in the Biotechnology industry.
Where is Generation Bio based?+
Generation Bio is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026